Department of Laboratory Medicine, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Front Immunol. 2023 Aug 18;14:1222425. doi: 10.3389/fimmu.2023.1222425. eCollection 2023.
Cell migration-inducing protein (CEMIP), also known as KIAA1199 and hyaluronan-binding protein involved in hyaluronan depolymerization, is a new member of the hyaluronidase family that degrades hyaluronic acid (HA) and remodels the extracellular matrix. In recent years, some studies have reported that CEMIP can promote the proliferation, invasion, and adhesion of various tumor cells and can play an important role in bacterial infection and arthritis. This review focuses on the pathological mechanism of CEMIP in a variety of diseases and expounds the function of CEMIP from the aspects of inhibiting cell apoptosis, promoting HA degradation, inducing inflammatory responses and related phosphorylation, adjusting cellular microenvironment, and regulating tissue fibrosis. The diagnosis and treatment strategies targeting CEMIP are also summarized. The various functions of CEMIP show its great potential application value.
细胞迁移诱导蛋白 (CEMIP),又称 KIAA1199 和参与透明质酸解聚的透明质酸结合蛋白,是透明质酸酶家族的一个新成员,可降解透明质酸 (HA) 并重塑细胞外基质。近年来,一些研究表明 CEMIP 可促进多种肿瘤细胞的增殖、侵袭和黏附,在细菌感染和关节炎中发挥重要作用。本综述重点关注 CEMIP 在多种疾病中的病理机制,并从抑制细胞凋亡、促进 HA 降解、诱导炎症反应及相关磷酸化、调节细胞微环境和调节组织纤维化等方面阐述 CEMIP 的功能。还总结了针对 CEMIP 的诊断和治疗策略。CEMIP 的各种功能显示出其巨大的潜在应用价值。